Top Story

AGS-003 plus sunitinib shows promise for advanced renal cell carcinoma

AGS-003 plus sunitinib shows promise for advanced renal cell carcinoma
May 21, 2015

The combination of AGS-003 and sunitinib yielded supportive immunologic responses and extended survival in intermediate- or poor-risk patients with metastatic renal cell carcinoma, according to data from a phase 2 trial.

AGS-003 (Argos Therapeutics) is a novel autologous immunotherapeutic agent created from the patient’s own dendritic cells co-electroporated with amplified tumor RNA and synthetic CD40L RNA, according to study background.

Brain, cardiac death allografts did not increase HCC recurrence In the Journals

Brain, cardiac death allografts did not increase HCC recurrence

May 21, 2015
Donations after brain and cardiac death allografts did not increase a patient’s likelihood of developing hepatocellular carcinoma recurrence after liver…
In the Journals

Combined surgical diagnostic tools improve gross total resection, not survival, in glioma

May 21, 2015
Intraoperative MRI and 5-aminolevulinic acid were not predictors of improved survival in patients with glioma when used together, according to data from a Swiss…
Scott F. Huntington, MD, MPH In the Journals

Surveillance imaging offers little benefit for DLBCL in first remission

May 21, 2015
Surveillance imaging of asymptomatic patients with diffuse large B-cell lymphoma who are in remission may have little benefit yet substantial costs, according to study…
Reshma Jagsi, MD, DPhil In the Journals

One-third of women with breast cancer desire genetic testing

May 21, 2015
Many women with nonmetastatic breast cancer expressed a strong desire for genetic testing, especially if they were younger or an ethnic minority, according to study…
More News Headlines »
CME
Hematology Oncology Case Consults

The Patient with Melanoma

No commercial support for this activity.

This CME activity will focus on the diagnosis and management of patients with melanoma.
More »
Meeting News Coverage Video
VIDEO: Updates in prostate cancer treatment options

VIDEO: Updates in prostate cancer treatment options

May 5, 2015
Robert S. DiPaola, MD, director of Rutgers Cancer Institute of New Jersey, discusses various forms of prostate cancer…
More »
CME
New Advances, New Options: Evaluating the Changing Landscape of Hemophilia

New Advances, New Options: Evaluating the Changing Landscape of Hemophilia to Optimize Patient Outcomes

This activity is supported by an educational grant from Biogen Idec.

The bleeding abnormalities associated with hemophilia can have devastating consequences for patients. Recent advances…
More »
morganatic-roan